• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LG 30435,一种新型潜在抗哮喘药物。

LG 30435, a new potential antiasthmatic agent.

作者信息

Berti F, Daffonchio L, Magni F, Omini C, Rossoni G, Subissi A

机构信息

Institute of Pharmacological Sciences, University of Milan, Italy.

出版信息

Eur Respir J. 1989 Oct;2(9):868-73.

PMID:2806514
Abstract

LG 30435 is a new quarternary phenothiazine derivative with H1-antihistaminic and antimuscarinic properties. The ability of LG 30435 to prevent changes in respiratory mechanics, induced by different mediators and the immunological reaction, was monitored together with biological and radioimmunological determination of circulating thromboxane-A2 (TxA2) in anaesthetized guinea-pigs. LG 30435 dose-dependently reduces the bronchoconstriction and TxA2 generation caused by different stimuli such as histamine, acetylcholine, leukotriene C4 (LTC4) and PAF-acether. In addition i.v. and aerosol administration of LG 30435 causes a dose-dependent reduction of the increase in airway resistance and TxA2 generation induced by ovalbumin challenge in actively sensitized animals. LG 30435 infused at different concentrations through the isolated guinea-pig lungs inhibits the TxB2 generation caused by different anaphylactic mediators, but not by arachidonic acid. These data, which further substantiate the bronchodilator activity of LG 30435 against a variety of stimuli and demonstrate its protective properties on lung anaphylaxis, suggest that this compound has a potential therapeutic value in the treatment of asthma.

摘要

LG 30435是一种新型的具有H1抗组胺和抗毒蕈碱特性的季铵类吩噻嗪衍生物。在麻醉的豚鼠中,监测LG 30435预防由不同介质和免疫反应诱导的呼吸力学变化的能力,同时对循环血栓素A2(TxA2)进行生物学和放射免疫测定。LG 30435剂量依赖性地减少由组胺、乙酰胆碱、白三烯C4(LTC4)和血小板活化因子(PAF-乙醚)等不同刺激引起的支气管收缩和TxA2生成。此外,静脉注射和气雾剂给药LG 30435可使主动致敏动物在卵清蛋白激发后气道阻力增加和TxA2生成呈剂量依赖性降低。通过分离的豚鼠肺以不同浓度输注LG 30435可抑制由不同过敏介质引起的TxB2生成,但不抑制花生四烯酸引起的TxB2生成。这些数据进一步证实了LG 30435对多种刺激的支气管扩张活性,并证明了其对肺过敏反应的保护特性,表明该化合物在哮喘治疗中具有潜在的治疗价值。

相似文献

1
LG 30435, a new potential antiasthmatic agent.LG 30435,一种新型潜在抗哮喘药物。
Eur Respir J. 1989 Oct;2(9):868-73.
2
New pharmacological data on the bronchospasmolytic activity of bamifylline.
Arzneimittelforschung. 1988 Jan;38(1):40-4.
3
Bronchodilating activity of mequitazine.美喹他嗪的支气管扩张活性。
Arch Int Pharmacodyn Ther. 1984 Mar;268(1):128-40.
4
Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis.
Int Arch Allergy Immunol. 1993;101(3):288-96. doi: 10.1159/000236460.
5
Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig.非甾体抗炎化合物尼美舒利在豚鼠体内的抗过敏性和抗组胺活性
Arzneimittelforschung. 1990 Sep;40(9):1011-6.
6
Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.新型选择性组胺H1受体拮抗剂咪唑斯汀在啮齿动物中的抗过敏活性。
Arzneimittelforschung. 1995 May;45(5):559-68.
7
Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.两种银杏内酯BN - 52020和BN - 52021对豚鼠肺过敏反应的保护作用。
Pharmacol Res Commun. 1986 Sep;18(9):775-93. doi: 10.1016/0031-6989(86)90129-3.
8
LG 30435 is a new bronchodilator agent with multiple sites of action.LG 30435是一种具有多种作用位点的新型支气管扩张剂。
Eur J Pharmacol. 1986 Jul 15;126(1-2):81-9. doi: 10.1016/0014-2999(86)90741-7.
9
LG 30435, a new bronchodilator/antiallergic agent, inhibits PAF-acether induced platelet aggregation and bronchoconstriction.新型支气管扩张剂/抗过敏药LG 30435可抑制血小板活化因子(PAF)诱导的血小板聚集和支气管收缩。
Agents Actions. 1986 Nov;19(3-4):246-50. doi: 10.1007/BF01966213.
10
Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm.1-[3-(4-二苯甲基-1-哌嗪基)丙基]-3-(1H-咪唑-1-基甲基)-1H-吲哚-6-羧酸(具有血栓素A2合成酶抑制和H1阻断活性)对过敏性支气管痉挛的作用。
Arzneimittelforschung. 1996 Nov;46(11):1067-71.